Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
$0.38
-4.6%
$0.38
$0.24
$1.06
$6.10M1.932.34 million shs367,144 shs
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
$0.09
-4.4%
$0.11
$4.10
$17.20
$5.82M0.0437,650 shs1.85 million shs
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
$3.17
+1.9%
$4.12
$2.90
$577.50
$2.30M0.19140,740 shs89,934 shs
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
$1.11
$1.31
$0.91
$15.79
$8.43M1.232.48 million shs103,219 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-4.62%-7.44%-0.47%-34.66%-9.64%
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-4.36%-8.92%-16.38%-57.21%-73.03%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
+1.93%+2.26%-20.35%-32.35%-99.99%
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
0.00%-5.13%-5.13%-21.83%+49.35%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
2.3828 of 5 stars
3.53.00.00.02.70.01.3
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
2.9899 of 5 stars
3.23.00.00.04.11.71.3
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
1.9234 of 5 stars
3.52.00.00.02.00.01.3
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
2.1722 of 5 stars
3.53.00.00.03.30.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
3.00
Buy$7.001,744.53% Upside
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
2.33
Hold$2.002,177.90% Upside
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
3.00
Buy$50.001,477.29% Upside
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
3.00
Buy$4.67320.42% Upside

Current Analyst Ratings Breakdown

Latest NDRA, LYRA, TNON, and AEMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2025
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
4/21/2025
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$75.00 ➝ $50.00
4/9/2025
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$3.00
3/14/2025
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$2.00 ➝ $2.00
3/10/2025
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$7.00 ➝ $7.00
(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
$570K10.69N/AN/A$2.19 per share0.17
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
$1.19M4.91N/AN/A$1.56 per share0.06
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/A$1,170.18 per shareN/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
$3.28M2.57N/AN/A$2.39 per share0.46
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
-$12.21M-$1.58N/AN/AN/AN/A-153.96%-109.13%6/26/2025 (Estimated)
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$62.68M-$1.21N/AN/AN/A-6,635.76%-125.07%-59.74%8/12/2025 (Estimated)
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
-$10.06M-$172.04N/AN/AN/AN/A-127.39%-103.77%8/13/2025 (Estimated)
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
-$15.58M-$27.23N/AN/A-413.88%-1,785.88%-164.26%8/11/2025 (Estimated)

Latest NDRA, LYRA, TNON, and AEMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
-$1.06-$1.01+$0.05-$1.01$0.76 million$0.73 million
5/6/2025Q1 2025
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$0.15-$0.12+$0.03-$0.13$0.16 million$0.18 million
3/31/2025Q4 2024
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
-$4.10-$9.40-$5.30-$20.78N/AN/A
3/13/2025Q4 2024
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
-$0.12-$0.16-$0.04-$0.16$0.21 million$0.21 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/AN/AN/AN/AN/A
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
N/AN/AN/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/AN/A
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
N/A
2.80
2.80
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
N/A
3.64
3.64
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/A
6.10
6.10
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
N/A
3.52
3.33

Institutional Ownership

CompanyInstitutional Ownership
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.99%
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
95.62%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
1.19%
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
22.74%

Insider Ownership

CompanyInsider Ownership
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1.10%
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
3.25%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
0.04%
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
4.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
1016.06 million14.30 millionNo Data
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
5066.27 million62.39 millionOptionable
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
20738,000537,000Not Optionable
Tenon Medical, Inc. stock logo
TNON
Tenon Medical
87.59 million2.99 millionNot Optionable

Recent News About These Companies

Tenon Medical initiated with a Buy at Alliance Global Partners
Tenon Medical prices $2.5M registered direct offering at $2.00

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aethlon Medical stock logo

Aethlon Medical NASDAQ:AEMD

$0.38 -0.02 (-4.62%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$0.38 0.00 (-0.13%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.

Lyra Therapeutics stock logo

Lyra Therapeutics NASDAQ:LYRA

$0.09 0.00 (-4.36%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$0.09 0.00 (-0.80%)
As of 05/27/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase III clinical trial; and LYR-220 for CRS patients with and without nasal polyps. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

ENDRA Life Sciences stock logo

ENDRA Life Sciences NASDAQ:NDRA

$3.17 +0.06 (+1.93%)
Closing price 05/27/2025 03:59 PM Eastern
Extended Trading
$3.15 -0.02 (-0.63%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Tenon Medical stock logo

Tenon Medical NASDAQ:TNON

$1.11 0.00 (0.00%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$1.10 -0.01 (-0.45%)
As of 08:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.